(NP -LCB-/-LRB- (NP Changes/NNS) (PP in/IN (NP (NP leucocytic/JJ estrogen/NN receptor/NN levels/NNS) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP gynecomastia/NN)))))) -RCB-/-RRB-)
(S (NP-SBJ-62 (NP The/DT number/NN) (PP of/IN (NP (NP (NP estrogen/NN receptor/NN) (PRN -LRB-/-LRB- (NP ER/NN) -RRB-/-RRB-)) (PP in/IN (NP (NP human/JJ peripheral/JJ leucocytes/NNS) (PP in/IN (NP (NP 13/CD men/NNS) (PP with/IN (NP gynecomastia/NNS))))))))) (VP were/VBD (VP measured/VBN (NP *-62/-NONE-) (PP by/IN (NP-LGS radioligand/NN binding/NN method/NN)))) ./.)
(S (NP-SBJ-63 The/DT results/NNS) (VP were/VBD (VP compared/VBN (NP *-63/-NONE-) (PP with/IN (NP (NP those/DT) (PP of/IN (NP 13/CD (ADJP sex-/NN and/CC age-matched/JJ) healthy/JJ subjects/NNS)))))) ./.)
(S (NP-SBJ It/PRP) (VP was/VBD (VP found/VBN (SBAR that/IN (S (NP-SBJ-64 (NP the/DT number/NN) (PP of/IN (NP (NP ER/NN) (PP in/IN (NP leucocytes/NNS))))) (VP was/VBD (ADVP significantly/RB) (VP increased/VBN (NP *-64/-NONE-) (PP in/IN (NP gynecomastia/NN)) (PRN -LRB-/-LRB- (S (NP-SBJ (NP Rs/NN) (PP of/IN (NP leucocytes/NNS))) (VP were/VBD (NP-PRD (QP 1054/CD +\/-/CC 254/CD) sites\/cell/NN))) -RRB-/-RRB-))))))) ./.)
(S (NP-SBJ It/PRP) (VP suggested/VBD (SBAR that/IN (S (NP-SBJ (NP increase/NN) (PP of/IN (NP ER/NN levels/NNS))) (VP play/VBP (NP an/DT important/JJ role/NN) (PP in/IN (NP (NP the/DT pathogenesis/NN) (PP of/IN (NP gynecomastia/NN)))))))) ./.)
